Core Scientific, Inc. CORZ Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $311.38M-62.8% | $836.98M+1,101% | $69.71M+33.4% | $52.24M-55.7% | ||
| $0-100% | $783K-95.9% | $19.3M-46.9% | $36.36M+163% | ||
| $120.91M+16.4% | $103.89M-13.9% | $120.65M-65.6% | $350.46M+1,003% | ||
| $895.54M-0.9% | $903.96M+832% | $97.02M+14.0% | $85.1M-88.8% | ||
| $1.29B+198% | $433.47M-26.0% | $585.43M-15.3% | $691.13M+15.7% | ||
| $9.86M— | —— | $293.97M— | —— | ||
| 10,848,400,000%-598,800,000% | 11,447,200,000%+10,662,800,000% | 784,400,000%-1,258,600,000% | 2,043,000,000%+1,373,000,000% | ||
| $50.32M+109% | $24.04M+9.9% | $21.87M+135% | $9.32M-55.7% | ||
| $161.14M— | —— | —— | —— | ||
| $2.35B+59.1% | $1.48B+107% | $712.16M-11.8% | $807.69M-66.9% | ||
| $559.67M+1,010% | $50.43M-83.4% | $304.61M+111% | $144.13M+1,012% | ||
| $15.78M-51.4% | $32.49M-81.9% | $179.64M+901% | $17.95M-73.5% | ||
| $555.85M+2,965% | $18.13M— | —— | $77.69M+22.5% | ||
| $0-100% | $1.67M-91.6% | $19.77M— | $0— | ||
| $12.34M+23.8% | $9.97M+12,853% | $77K-90.0% | $769K+285% | ||
| $0-100% | $1.67M-91.6% | $19.77M— | $0— | ||
| $1.97M+465% | $349K-96.4% | $9.8M— | —— | ||
| $781.4M+481% | $134.56M-72.4% | $488.42M+161% | $186.79M-41.7% | ||
| $1.06B-1.3% | $1.07B+57.0% | $684.08M— | $0-100% | ||
| $89.01M-9.0% | $97.84M+6,371% | $1.51M+110% | $720K-40.0% | ||
| $844K-49.5% | $1.67M-97.0% | $55.52M— | $0— | ||
| $101.35M-6.0% | $107.82M+6,685% | $1.59M+6.7% | $1.49M— | ||
| $844K+28,033% | $3K-100.0% | $35.75M— | $0-100% | ||
| $104.26M-7.9% | $113.16M— | $0-100% | $2.21M-88.1% | ||
| $3.31B+36.8% | $2.42B+84.8% | $1.31B+7.6% | $1.22B+15.6% | ||
| $0— | $0— | $0— | —— | ||
| 10B+333,333,233% | 3K-91.7% | 36K0.0% | 36K+33.3% | ||
| $3.18B+9.2% | $2.92B+59.9% | $1.82B+3.3% | $1.76B+27.9% | ||
| -$4.15B-7.5% | -$3.86B-59.4% | -$2.42B-11.3% | -$2.17B-7,824% | ||
| -$962.74M-2.1% | -$943.05M-58.0% | -$596.94M-45.8% | -$409.35M-131% | ||
| $2.35B+59.1% | $1.48B+107% | $712.16M-11.8% | $807.69M-66.9% | ||
| $222M+829% | $23.89M+946% | $2.28M+215% | $724K— | ||
| $362.16M+740% | $43.09M— | —— | —— | ||
| $25M-40.6% | $42.06M+75.1% | $24.02M-24.7% | $31.88M+5.9% | ||
| $222M+829% | $23.89M+946% | $2.28M— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $9.86M— | —— | —— | —— | ||
| $50.32M+109% | $24.04M+9.9% | $21.87M+135% | $9.32M-55.7% | ||
| $161.14M+40.8% | $114.47M+1,359% | $7.84M-61.6% | $20.43M+205% | ||
| $222M+829% | $23.89M+946% | $2.28M— | —— | ||
| $108.48M-5.2% | $114.47M+1,359% | $7.84M-61.6% | $20.43M+205% | ||
| $50.32M+109% | $24.04M+9.9% | $21.87M+135% | $9.32M-55.7% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $108.48M-5.2% | $114.47M+1,359% | $7.84M-61.6% | $20.43M+205% | ||
| $50.32M+109% | $24.04M+9.9% | $21.87M+135% | $9.32M-55.7% | ||
| $511.96M+692% | $64.67M-64.0% | $179.64M+901% | $17.95M-73.5% | ||
| $511.96M+692% | $64.67M-64.0% | $179.64M+901% | $17.95M-73.5% | ||
| $127.56M+603% | $18.13M— | —— | —— | ||
| $0— | —— | —— | —— | ||
| $15.78M-51.4% | $32.49M— | —— | —— | ||
| $0-100% | $1.1B— | $0— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $24.68M— | —— | —— | —— | ||
| $936.11M-14.7% | $1.1B— | $0— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $428.29M— | $0— | —— | —— | ||
| $1.16B-1.9% | $1.19B+55.7% | $760.96M+51,005% | $1.49M-99.8% | ||
| $0.000.0% | $0.000.0% | $0.00— | —— | ||
| 314.2M+7.4% | 292.6M-24.4% | 386.9M— | —— | ||
| 2B0.0% | 2B— | 0— | —— | ||
| 0— | 0— | 0— | —— | ||
| 0— | 0— | 0— | —— | ||
| $3K0.0% | $3K-91.7% | $36K0.0% | $36K+33.3% | ||
| $0— | $0— | $0— | —— | ||
| $0.000.0% | $0.000.0% | $0.00— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $197.89M+1,535% | $12.11M— | —— | —— | ||
| $290.6M— | $0— | —— | —— | ||
| $290.6M— | —— | —— | —— | ||
| $00.0% | $00.0% | $0— | —— | ||
| $10B0.0% | $10B0.0% | $10B— | —— | ||
| $314.23M+7.4% | $292.61M-24.4% | $386.88M— | —— | ||
| $314.23M+7.4% | $292.61M-24.4% | $386.88M— | —— | ||
| $1.97M+465% | $349K-96.4% | $9.8M— | —— | ||
| $400K-55.6% | $900K-47.1% | $1.7M— | —— | ||
| $46.6M— | —— | —— | —— | ||
| $337.16M+4,430% | $7.44M— | —— | —— | ||
| $11.04M— | —— | —— | —— | ||
| $0— | —— | —— | —— | ||
| $24.68M— | —— | —— | —— | ||
| $1.09B— | —— | —— | —— | ||
| $553.88M+3,014% | $17.79M— | —— | —— | ||
| $936.11M-14.7% | $1.1B— | $0— | —— | ||
| —— | —— | —— | —— | ||
| $0-100% | $1.67M-91.6% | $19.77M— | $0— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $1.84M-68.6% | $5.87M-63.9% | $16.27M— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| 10.0% | 1— | —— | —— | ||
| —— | —— | —— | —— | ||
| $23.47M-32.9% | $34.95M— | —— | —— | ||
| $4.21M-72.5% | $15.32M— | —— | —— | ||
| $00.0% | $00.0% | $0— | —— | ||
| $2B0.0% | $2B— | $0— | —— | ||
| $0— | $0— | $0— | —— | ||
| $0— | $0— | $0— | —— | ||
| $406.89M— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Core Scientific, Inc.'s total assets?
- Core Scientific, Inc. (CORZ) holds $3.1B in total assets, up 88.8% year over year.
- How much debt does Core Scientific, Inc. have?
- Core Scientific, Inc. carries $2.2B in total debt against -$1.3B of shareholders' equity, a debt-to-equity ratio of 2.21.
- How much cash does Core Scientific, Inc. have?
- Core Scientific, Inc. holds $1.1B in cash and equivalents.
- Can Core Scientific, Inc. cover its short-term obligations?
- Its current ratio is 0.55 — current liabilities exceed current assets.
- Where does Core Scientific, Inc.'s balance sheet data come from?
- Every line is extracted from Core Scientific, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
